Hironoshin Nomura
Govt Officer & CFO
[Interpreted] It’s time. From now, we want to begin Nxera Pharma’s FY 2025 Full Yr Monetary Outcomes Briefing. Thanks very a lot for becoming a member of regardless of your very busy schedule. I might be serving because the MC in the present day, CFO, Nomura.
At this time, we now have Mr. Chris Cargill, CEO; COO, President and Nxera Pharma, Japan, Toshihiro Maeda; CSO, President and Nxera Pharma, U.Okay., Dr. Patrik Foerch attending the assembly.
We’ve simultaneous interpretation as normal. Please click on the globe icon and choose the language, Japanese or English and it is possible for you to to listen to the interpreter’s voice. If not, it is possible for you to to listen to the unique voice of the audio system.
Within the first half, I might be presenting, and there might be Q&A session within the second half of the session. We’ve the supplies shared on the display. We’re additionally importing on the web site. If you want to have the supplies from Traders, IR Library, Presentation, please entry the supplies.
Within the latter half of the session in Q&A, institutional buyers, analysts and media individuals, it is possible for you to to ask questions by elevating hand. The others will have the ability to submit questions from Q&A button. It is possible for you to to submit questions at any time and we want to reply to your questions as
